top of page
800-958-1129 (TTY: 711)
We are open M-F 8:00 a.m. – 8:00 p.m. PT. Between 10/1 and 3/31, we are open 7 days a week, except for the major year-end holidays. You can enroll beginning 10/15/2025.
_edited.png){kind=logo}
National Medicare Coverage Determinations
ID | Title | Link Title |
|---|---|---|
10.1 | Use of Visual Tests Prior to and General Anesthesia during Cataract Surgery | NCD - Use of Visual Tests Prior to and General Anesthesia during Cataract Surgery (10.1) (cms.gov) |
10.2 | Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post-Operative Pain | NCD - Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post-Operative Pain (10.2) (cms.gov) |
10.3 | Inpatient Hospital Pain Rehabilitation Programs | NCD - Inpatient Hospital Pain Rehabilitation Programs (10.3) (cms.gov) |
10.4 | Outpatient Hospital Pain Rehabilitation Programs | NCD - Outpatient Hospital Pain Rehabilitation Programs (10.4) (cms.gov) |
10.5 | Autogenous Epidural Blood Graft | NCD - Autogenous Epidural Blood Graft (10.5) (cms.gov) |
10.6 | Anesthesia in Cardiac Pacemaker Surgery | NCD - Anesthesia in Cardiac Pacemaker Surgery (10.6) (cms.gov) |
100.1 | Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity | NCD - Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity (100.1) (cms.gov) |
100.10 | Injection Sclerotherapy for Esophageal Variceal Bleeding | NCD - Injection Sclerotherapy for Esophageal Variceal Bleeding (100.10) (cms.gov) |
100.12 | Gastrophotography | NCD - Gastrophotography (100.12) (cms.gov) |
100.13 | Laparoscopic Cholecystectomy | NCD - Laparoscopic Cholecystectomy (100.13) (cms.gov) |
100.2 | Endoscopy | NCD - Endoscopy (100.2) (cms.gov) |
100.3 | 24-Hour Ambulatory Esophageal pH Monitoring | NCD - 24-Hour Ambulatory Esophageal pH Monitoring (100.3) (cms.gov) |
100.4 | Esophageal Manometry | NCD - Esophageal Manometry (100.4) (cms.gov) |
100.5 | Diagnostic Breath Analyses | NCD - Diagnostic Breath Analyses (100.5) (cms.gov) |
100.6 | Gastric Freezing | NCD - Gastric Freezing (100.6) (cms.gov) |
100.7 | Colonic Irrigation | NCD - Colonic Irrigation (100.7) (cms.gov) |
100.8 | Intestinal Bypass Surgery - RETIRED | NCD - Intestinal Bypass Surgery - RETIRED (100.8) (cms.gov) |
110.1 | Hyperthermia for Treatment of Cancer | NCD - Hyperthermia for Treatment of Cancer (110.1) (cms.gov) |
110.10 | Intravenous Iron Therapy | NCD - Intravenous Iron Therapy (110.10) (cms.gov) |
110.11 | Food Allergy Testing and Treatment | NCD - Food Allergy Testing and Treatment (110.11) (cms.gov) |
110.12 | Challenge Ingestion Food Testing | NCD - Challenge Ingestion Food Testing (110.12) (cms.gov) |
110.13 | Cytotoxic Food Tests | NCD - Cytotoxic Food Tests (110.13) (cms.gov) |
110.14 | Apheresis (Therapeutic Pheresis) | NCD - Apheresis (Therapeutic Pheresis) (110.14) (cms.gov) |
110.15 | Ultrafiltration, Hemoperfusion and Hemofiltration | NCD - Ultrafiltration, Hemoperfusion and Hemofiltration (110.15) (cms.gov) |
110.16 | Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney Transplantation | NCD - Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney Transplantation (110.16) (cms.gov) |
110.17 | Anti-Cancer Chemotherapy for Colorectal Cancer | NCD - Anti-Cancer Chemotherapy for Colorectal Cancer (110.17) (cms.gov) |
110.18 | Aprepitant for Chemotherapy-Induced Emesis | NCD - Aprepitant for Chemotherapy-Induced Emesis (110.18) (cms.gov) |
110.2 | Certain Drugs Distributed by the National Cancer Institute | NCD - Certain Drugs Distributed by the National Cancer Institute (110.2) (cms.gov) |
110.20 | Blood Brain Barrier Osmotic Disruption for Treatment of Brain Tumors | NCD - Blood Brain Barrier Osmotic Disruption for Treatment of Brain Tumors (110.20) (cms.gov) |
110.21 | Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions | NCD - Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions (110.21) (cms.gov) |
110.22 | Autologous Cellular Immunotherapy Treatment | NCD - Autologous Cellular Immunotherapy Treatment (110.22) (cms.gov) |
110.23 | Stem Cell Transplantation (Formerly 110.8.1) | NCD - Stem Cell Transplantation (Formerly 110.8.1) (110.23) (cms.gov) |
110.24 | Chimeric Antigen Receptor (CAR) T-cell Therapy | NCD - Chimeric Antigen Receptor (CAR) T-cell Therapy (110.24) (cms.gov) |
110.3 | Anti-Inhibitor Coagulant Complex (AICC) | NCD - Anti-Inhibitor Coagulant Complex (AICC) (110.3) (cms.gov) |
110.4 | Extracorporeal Photopheresis | NCD - Extracorporeal Photopheresis (110.4) (cms.gov) |
110.5 | Granulocyte Transfusions | NCD - Granulocyte Transfusions (110.5) (cms.gov) |
110.6 | Scalp Hypothermia During Chemotherapy to Prevent Hair Loss | NCD - Scalp Hypothermia During Chemotherapy to Prevent Hair Loss (110.6) (cms.gov) |
110.7 | Blood Transfusions | NCD - Blood Transfusions (110.7) (cms.gov) |
110.8 | Blood Platelet Transfusions | NCD - Blood Platelet Transfusions (110.8) (cms.gov) |
110.9 | Antigens Prepared for Sublingual Administration | NCD - Antigens Prepared for Sublingual Administration (110.9) (cms.gov) |
130.1 | Inpatient Hospital Stays for Treatment of Alcoholism | NCD - Inpatient Hospital Stays for Treatment of Alcoholism (130.1) (cms.gov) |
130.2 | Outpatient Hospital Services for Treatment of Alcoholism | NCD - Outpatient Hospital Services for Treatment of Alcoholism (130.2) (cms.gov) |
130.3 | Chemical Aversion Therapy for Treatment of Alcoholism | NCD - Chemical Aversion Therapy for Treatment of Alcoholism (130.3) (cms.gov) |
130.4 | Electrical Aversion Therapy for Treatment of Alcoholism | NCD - Electrical Aversion Therapy for Treatment of Alcoholism (130.4) (cms.gov) |
130.5 | Treatment of Alcoholism and Drug Abuse in a Freestanding Clinic | NCD - Treatment of Alcoholism and Drug Abuse in a Freestanding Clinic (130.5) (cms.gov) |
130.6 | Treatment of Drug Abuse (Chemical Dependency) | NCD - Treatment of Drug Abuse (Chemical Dependency) (130.6) (cms.gov) |
130.7 | Withdrawal Treatments for Narcotic Addictions | NCD - Withdrawal Treatments for Narcotic Addictions (130.7) (cms.gov) |
130.8 | Hemodialysis for Treatment of Schizophrenia | NCD - Hemodialysis for Treatment of Schizophrenia (130.8) (cms.gov) |
140.2 | Breast Reconstruction Following Mastectomy | NCD - Breast Reconstruction Following Mastectomy (140.2) (cms.gov) |
140.5 | Laser Procedures | NCD - Laser Procedures (140.5) (cms.gov) |
140.6 | Wrong Surgical or Other Invasive Procedure Performed on a Patient | NCD - Wrong Surgical or Other Invasive Procedure Performed on a Patient (140.6) (cms.gov) |
140.7 | Surgical or Other Invasive Procedure Performed on the Wrong Body Part | NCD - Surgical or Other Invasive Procedure Performed on the Wrong Body Part (140.7) (cms.gov) |
140.8 | Surgical or Other Invasive Procedure Performed on the Wrong Patient | NCD - Surgical or Other Invasive Procedure Performed on the Wrong Patient (140.8) (cms.gov) |
140.9 | Gender Dysphoria and Gender Reassignment Surgery | NCD - Gender Dysphoria and Gender Reassignment Surgery (140.9) (cms.gov) |
150.1 | Manipulation | NCD - Manipulation (150.1) (cms.gov) |
150.10 | Lumbar Artificial Disc Replacement (LADR) | NCD - Lumbar Artificial Disc Replacement (LADR) (150.10) (cms.gov) |
150.11 | Thermal Intradiscal Procedures (TIPs) | NCD - Thermal Intradiscal Procedures (TIPs) (150.11) (cms.gov) |
150.12 | Collagen Meniscus Implant | NCD - Collagen Meniscus Implant (150.12) (cms.gov) |
150.13 | Percutaneous Image-Guided Lumbar Decompression for Lumbar Spinal Stenosis | NCD - Percutaneous Image-Guided Lumbar Decompression for Lumbar Spinal Stenosis (150.13) (cms.gov) |
150.2 | Osteogenic Stimulators | NCD - Osteogenic Stimulators (150.2) (cms.gov) |
150.3 | Bone (Mineral) Density Studies | NCD - Bone (Mineral) Density Studies (150.3) (cms.gov) |
150.5 | Diathermy Treatment | NCD - Diathermy Treatment (150.5) (cms.gov) |
150.6 | Vitamin B12 Injections to Strengthen Tendons, Ligaments, etc., of the Foot | NCD - Vitamin B12 Injections to Strengthen Tendons, Ligaments, etc., of the Foot (150.6) (cms.gov) |
150.7 | Prolotherapy, Joint Sclerotherapy, and Ligamentous Injections with Sclerosing Agents | NCD - Prolotherapy, Joint Sclerotherapy, and Ligamentous Injections with Sclerosing Agents (150.7) (cms.gov) |
150.8 | Fluidized Therapy Dry Heat for Certain Musculoskeletal Disorders | NCD - Fluidized Therapy Dry Heat for Certain Musculoskeletal Disorders (150.8) (cms.gov) |
150.9 | Arthroscopic Lavage and Arthroscopic Debridement for the Osteoarthritic Knee | NCD - Arthroscopic Lavage and Arthroscopic Debridement for the Osteoarthritic Knee (150.9) (cms.gov) |
160.1 | Induced Lesions of Nerve Tracts | NCD - Induced Lesions of Nerve Tracts (160.1) (cms.gov) |
160.10 | Evoked Response Tests | NCD - Evoked Response Tests (160.10) (cms.gov) |
160.12 | Neuromuscular Electrical Stimulation (NMES) | NCD - Neuromuscular Electrical Stimulation (NMES) (160.12) (cms.gov) |
160.13 | Supplies Used in the Delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES) | NCD - Supplies Used in the Delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES) (160.13) (cms.gov) |
160.14 | Invasive Intracranial Pressure Monitoring | NCD - Invasive Intracranial Pressure Monitoring (160.14) (cms.gov) |
160.15 | Electrotherapy for Treatment of Facial Nerve Paralysis (Bell's Palsy) | NCD - Electrotherapy for Treatment of Facial Nerve Paralysis (Bell's Palsy) (160.15) (cms.gov) |
160.16 | Vertebral Axial Decompression (VAX-D) | NCD - Vertebral Axial Decompression (VAX-D) (160.16) (cms.gov) |
160.17 | L-Dopa | NCD - L-Dopa (160.17) (cms.gov) |
160.18 | Vagus Nerve Stimulation (VNS) | NCD - Vagus Nerve Stimulation (VNS) (160.18) (cms.gov) |
160.19 | Phrenic Nerve Stimulator | NCD - Phrenic Nerve Stimulator (160.19) (cms.gov) |
160.2 | Treatment of Motor Function Disorders with Electric Nerve Stimulation | NCD - Treatment of Motor Function Disorders with Electric Nerve Stimulation (160.2) (cms.gov) |
160.20 | Transfer Factor for Treatment of Multiple Sclerosis | NCD - Transfer Factor for Treatment of Multiple Sclerosis (160.20) (cms.gov) |
160.21 | Telephone Transmission of EEGs | NCD - Telephone Transmission of EEGs (160.21) (cms.gov) |
160.23 | Sensory Nerve Conduction Threshold Tests (sNCTs) | NCD - Sensory Nerve Conduction Threshold Tests (sNCTs) (160.23) (cms.gov) |
160.24 | Deep Brain Stimulation for Essential Tremor and Parkinson’s Disease | NCD - Deep Brain Stimulation for Essential Tremor and Parkinson’s Disease (160.24) (cms.gov) |
160.25 | Multiple Electroconvulsive Therapy (MECT) | NCD - Multiple Electroconvulsive Therapy (MECT) (160.25) (cms.gov) |
160.26 | Cavernous Nerves by Electrical Stimulation with Penile Plethsmography | NCD - Cavernous Nerves by Electrical Stimulation with Penile Plethsmography (160.26) (cms.gov) |
160.27 | Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Low Back Pain (CLBP) | NCD - Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Low Back Pain (CLBP) (160.27) (cms.gov) |
160.5 | Stereotaxic Depth Electrode Implantation | NCD - Stereotaxic Depth Electrode Implantation (160.5) (cms.gov) |
160.7 | Electrical Nerve Stimulators | NCD - Electrical Nerve Stimulators (160.7) (cms.gov) |
160.7.1 | Assessing Patient's Suitability for Electrical Nerve Stimulation Therapy | NCD - Assessing Patient's Suitability for Electrical Nerve Stimulation Therapy (160.7.1) (cms.gov) |
160.8 | Electroencephalographic Monitoring During Surgical Procedures Involving the Cerebral Vasculature | NCD - Electroencephalographic Monitoring During Surgical Procedures Involving the Cerebral Vasculature (160.8) (cms.gov) |
170.1 | Institutional and Home Care Patient Education Programs | NCD - Institutional and Home Care Patient Education Programs (170.1) (cms.gov) |
170.2 | Melodic Intonation Therapy | NCD - Melodic Intonation Therapy (170.2) (cms.gov) |
170.3 | Speech-Language Pathology Services for the Treatment of Dysphagia | NCD - Speech-Language Pathology Services for the Treatment of Dysphagia (170.3) (cms.gov) |
180.1 | Medical Nutrition Therapy | NCD - Medical Nutrition Therapy (180.1) (cms.gov) |
190.1 | Histocompatibility Testing | NCD - Histocompatibility Testing (190.1) (cms.gov) |
190.10 | Laboratory Tests - CRD Patients | NCD - Laboratory Tests - CRD Patients (190.10) (cms.gov) |
190.11 | Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation Management | NCD - Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation Management (190.11) (cms.gov) |
190.12 | Urine Culture, Bacterial | NCD - Urine Culture, Bacterial (190.12) (cms.gov) |
190.13 | Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) | NCD - Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) (190.13) (cms.gov) |
190.14 | Human Immunodeficiency Virus (HIV) Testing (Diagnosis) | NCD - Human Immunodeficiency Virus (HIV) Testing (Diagnosis) (190.14) (cms.gov) |
190.15 | Blood Counts | NCD - Blood Counts (190.15) (cms.gov) |
190.16 | Partial ThromboplastinTime (PTT) | NCD - Partial ThromboplastinTime (PTT) (190.16) (cms.gov) |
190.17 | Prothrombin Time (PT) | NCD - Prothrombin Time (PT) (190.17) (cms.gov) |
190.18 | Serum Iron Studies | NCD - Serum Iron Studies (190.18) (cms.gov) |
190.19 | Collagen Crosslinks, any Method | NCD - Collagen Crosslinks, any Method (190.19) (cms.gov) |
190.2 | Diagnostic Pap Smears | NCD - Diagnostic Pap Smears (190.2) (cms.gov) |
190.20 | Blood Glucose Testing | NCD - Blood Glucose Testing (190.20) (cms.gov) |
190.21 | Glycated Hemoglobin/Glycated Protein | NCD - Glycated Hemoglobin/Glycated Protein (190.21) (cms.gov) |
190.22 | Thyroid Testing | NCD - Thyroid Testing (190.22) (cms.gov) |
190.23 | Lipid Testing | NCD - Lipid Testing (190.23) (cms.gov) |
190.24 | Digoxin Therapeutic Drug Assay | NCD - Digoxin Therapeutic Drug Assay (190.24) (cms.gov) |
190.25 | Alpha-fetoprotein | NCD - Alpha-fetoprotein (190.25) (cms.gov) |
190.26 | Carcinoembryonic Antigen | NCD - Carcinoembryonic Antigen (190.26) (cms.gov) |
190.27 | Human Chorionic Gonadotropin | NCD - Human Chorionic Gonadotropin (190.27) (cms.gov) |
190.28 | Tumor Antigen by Immunoassay - CA 125 | NCD - Tumor Antigen by Immunoassay - CA 125 (190.28) (cms.gov) |
190.29 | Tumor Antigen by Immunoassay - CA 15-3/CA 27.29 | NCD - Tumor Antigen by Immunoassay - CA 15-3/CA 27.29 (190.29) (cms.gov) |
190.3 | Cytogenetic Studies | NCD - Cytogenetic Studies (190.3) (cms.gov) |
190.30 | Tumor Antigen by Immunoassay - CA 19-9 | NCD - Tumor Antigen by Immunoassay - CA 19-9 (190.30) (cms.gov) |
190.31 | Prostate Specific Antigen | NCD - Prostate Specific Antigen (190.31) (cms.gov) |
190.32 | Gamma Glutamyl Transferase | NCD - Gamma Glutamyl Transferase (190.32) (cms.gov) |
190.33 | Hepatitis Panel/Acute Hepatitis Panel | NCD - Hepatitis Panel/Acute Hepatitis Panel (190.33) (cms.gov) |
190.34 | Fecal Occult Blood Test | NCD - Fecal Occult Blood Test (190.34) (cms.gov) |
190.5 | Sweat Test | NCD - Sweat Test (190.5) (cms.gov) |
190.6 | Hair Analysis | NCD - Hair Analysis (190.6) (cms.gov) |
190.7 | Human Tumor Stem Cell Drug Sensitivity Assays | NCD - Human Tumor Stem Cell Drug Sensitivity Assays (190.7) (cms.gov) |
190.8 | Lymphocyte Mitogen Response Assays | NCD - Lymphocyte Mitogen Response Assays (190.8) (cms.gov) |
190.9 | Serologic Testing for Acquired Immunodeficiency Syndrome (AIDS) | NCD - Serologic Testing for Acquired Immunodeficiency Syndrome (AIDS) (190.9) (cms.gov) |
20.1 | Vertebral Artery Surgery | NCD - Vertebral Artery Surgery (20.1) (cms.gov) |
20.10.1 | Cardiac Rehabilitation Programs for Chronic Heart Failure | NCD - Cardiac Rehabilitation Programs for Chronic Heart Failure (20.10.1) (cms.gov) |
20.11 | Intraoperative Ventricular Mapping | NCD - Intraoperative Ventricular Mapping (20.11) (cms.gov) |
20.12 | Diagnostic Endocardial Electrical Stimulation (Pacing) | NCD - Diagnostic Endocardial Electrical Stimulation (Pacing) (20.12) (cms.gov) |
20.13 | HIS Bundle Study | NCD - HIS Bundle Study (20.13) (cms.gov) |
20.14 | Plethysmography | NCD - Plethysmography (20.14) (cms.gov) |
20.15 | Electrocardiographic Services | NCD - Electrocardiographic Services (20.15) (cms.gov) |
20.16 | Cardiac Output Monitoring by Thoracic Electrical Bioimpedance (TEB) | NCD - Cardiac Output Monitoring by Thoracic Electrical Bioimpedance (TEB) (20.16) (cms.gov) |
20.17 | Noninvasive Tests of Carotid Function | NCD - Noninvasive Tests of Carotid Function (20.17) (cms.gov) |
20.18 | Carotid Body Resection/Carotid Body Denervation | NCD - Carotid Body Resection/Carotid Body Denervation (20.18) (cms.gov) |
20.19 | Ambulatory Blood Pressure Monitoring | NCD - Ambulatory Blood Pressure Monitoring (20.19) (cms.gov) |
20.2 | Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery | NCD - Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery (20.2) (cms.gov) |
20.20 | External Counterpulsation (ECP) Therapy for Severe Angina | NCD - External Counterpulsation (ECP) Therapy for Severe Angina (20.20) (cms.gov) |
20.21 | Chelation Therapy for Treatment of Atherosclerosis | NCD - Chelation Therapy for Treatment of Atherosclerosis (20.21) (cms.gov) |
20.22 | Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis | NCD - Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis (20.22) (cms.gov) |
20.23 | Fabric Wrapping of Abdominal Aneurysms | NCD - Fabric Wrapping of Abdominal Aneurysms (20.23) (cms.gov) |
20.24 | Displacement Cardiography | NCD - Displacement Cardiography (20.24) (cms.gov) |
20.25 | Cardiac Catheterization Performed in Other than a Hospital Setting - RETIRED | NCD - Cardiac Catheterization Performed in Other than a Hospital Setting - RETIRED (20.25) (cms.gov) |
20.26 | Partial Ventriculectomy | NCD - Partial Ventriculectomy (20.26) (cms.gov) |
20.27 | Cardiointegram (CIG) as an Alternative to Stress Test or Thallium Stress Test | NCD - Cardiointegram (CIG) as an Alternative to Stress Test or Thallium Stress Test (20.27) (cms.gov) |
20.28 | Therapeutic Embolization | NCD - Therapeutic Embolization (20.28) (cms.gov) |
20.29 | Hyperbaric Oxygen Therapy | NCD - Hyperbaric Oxygen Therapy (20.29) (cms.gov) |
20.3 | Thoracic Duct Drainage (TDD) in Renal Transplants | NCD - Thoracic Duct Drainage (TDD) in Renal Transplants (20.3) (cms.gov) |
20.30 | Microvolt T-Wave Alternans (MTWA) | NCD - Microvolt T-Wave Alternans (MTWA) (20.30) (cms.gov) |
20.31 | Intensive Cardiac Rehabilitation (ICR) Programs | NCD - Intensive Cardiac Rehabilitation (ICR) Programs (20.31) (cms.gov) |
20.31.1 | The Pritikin Program | NCD - The Pritikin Program (20.31.1) (cms.gov) |
20.31.2 | Ornish Program for Reversing Heart Disease | NCD - Ornish Program for Reversing Heart Disease (20.31.2) (cms.gov) |
20.31.3 | Benson-Henry Institute Cardiac Wellness Program | NCD - Benson-Henry Institute Cardiac Wellness Program (20.31.3) (cms.gov) |
20.32 | Transcatheter Aortic Valve Replacement (TAVR) | NCD - Transcatheter Aortic Valve Replacement (TAVR) (20.32) (cms.gov) |
20.33 | Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve Regurgitation | NCD - Transcatheter Edge-to-Edge Repair (TEER) for Mitral Valve Regurgitation (20.33) (cms.gov) |
20.34 | Percutaneous Left Atrial Appendage Closure (LAAC) | NCD - Percutaneous Left Atrial Appendage Closure (LAAC) (20.34) (cms.gov) |
20.35 | Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD) | NCD - Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD) (20.35) (cms.gov) |
20.4 | Implantable Cardioverter Defibrillators (ICDs) | NCD - Implantable Cardioverter Defibrillators (ICDs) (20.4) (cms.gov) |
20.6 | Transmyocardial Revascularization (TMR) | NCD - Transmyocardial Revascularization (TMR) (20.6) (cms.gov) |
20.7 | Percutaneous Transluminal Angioplasty (PTA) | NCD - Percutaneous Transluminal Angioplasty (PTA) (20.7) (cms.gov) |
20.8 | Cardiac Pacemakers | NCD - Cardiac Pacemakers (20.8) (cms.gov) |
20.8.1 | Cardiac Pacemaker Evaluation Services | NCD - Cardiac Pacemaker Evaluation Services (20.8.1) (cms.gov) |
20.8.1.1 | Transtelephonic Monitoring of Cardiac Pacemakers | NCD - Transtelephonic Monitoring of Cardiac Pacemakers (20.8.1.1) (cms.gov) |
20.8.2 | Self-Contained Pacemaker Monitors | NCD - Self-Contained Pacemaker Monitors (20.8.2) (cms.gov) |
20.8.3 | Cardiac Pacemakers: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers | NCD - Cardiac Pacemakers: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers (20.8.3) (cms.gov) |
20.8.4 | Leadless Pacemakers | NCD - Leadless Pacemakers (20.8.4) (cms.gov) |
20.9.1 | Ventricular Assist Devices | NCD - Ventricular Assist Devices (20.9.1) (cms.gov) |
200.1 | Nesiritide for Treatment of Heart Failure Patients | NCD - Nesiritide for Treatment of Heart Failure Patients (200.1) (cms.gov) |
200.2 | Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases | NCD - Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases (200.2) (cms.gov) |
200.3 | Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD) | NCD - Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD) (200.3) (cms.gov) |
210.1 | Prostate Cancer Screening Tests | NCD - Prostate Cancer Screening Tests (210.1) (cms.gov) |
210.10 | Screening for Sexually Transmitted Infections (STIs) and High-Intensity Behavioral Counseling (HIBC) to Prevent STIs | NCD - Screening for Sexually Transmitted Infections (STIs) and High-Intensity Behavioral Counseling (HIBC) to Prevent STIs (210.10) (cms.gov) |
210.11 | Intensive Behavioral Therapy for Cardiovascular Disease | NCD - Intensive Behavioral Therapy for Cardiovascular Disease (210.11) (cms.gov) |
210.12 | Intensive Behavioral Therapy for Obesity | NCD - Intensive Behavioral Therapy for Obesity (210.12) (cms.gov) |
210.13 | Screening for Hepatitis C Virus (HCV) in Adults | NCD - Screening for Hepatitis C Virus (HCV) in Adults (210.13) (cms.gov) |
210.14 | Lung Cancer Screening with Low Dose Computed Tomography (LDCT) | NCD - Lung Cancer Screening with Low Dose Computed Tomography (LDCT) (210.14) (cms.gov) |
210.2 | Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer | NCD - Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer (210.2) (cms.gov) |
210.2.1 | Screening for Cervical Cancer with Human Papillomavirus (HPV) | NCD - Screening for Cervical Cancer with Human Papillomavirus (HPV) (210.2.1) (cms.gov) |
210.3 | Colorectal Cancer Screening Tests | NCD - Colorectal Cancer Screening Tests (210.3) (cms.gov) |
210.4.1 | Counseling to Prevent Tobacco Use | NCD - Counseling to Prevent Tobacco Use (210.4.1) (cms.gov) |
210.6 | Screening for Hepatitis B Virus (HBV) Infection | NCD - Screening for Hepatitis B Virus (HBV) Infection (210.6) (cms.gov) |
210.7 | Screening for the Human Immunodeficiency Virus (HIV) Infection | NCD - Screening for the Human Immunodeficiency Virus (HIV) Infection (210.7) (cms.gov) |
210.8 | Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse | NCD - Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse (210.8) (cms.gov) |
210.9 | Screening for Depression in Adults | NCD - Screening for Depression in Adults (210.9) (cms.gov) |
220.1 | Computed Tomography | NCD - Computed Tomography (220.1) (cms.gov) |
220.10 | Portable Hand-Held X-Ray Instrument | NCD - Portable Hand-Held X-Ray Instrument (220.10) (cms.gov) |
220.11 | Thermography | NCD - Thermography (220.11) (cms.gov) |
220.12 | Single Photon Emission Computed Tomography (SPECT) | NCD - Single Photon Emission Computed Tomography (SPECT) (220.12) (cms.gov) |
220.13 | Percutaneous Image-Guided Breast Biopsy | NCD - Percutaneous Image-Guided Breast Biopsy (220.13) (cms.gov) |
220.2 | Magnetic Resonance Imaging | NCD - Magnetic Resonance Imaging (220.2) (cms.gov) |
220.4 | Mammograms | NCD - Mammograms (220.4) (cms.gov) |
220.5 | Ultrasound Diagnostic Procedures | NCD - Ultrasound Diagnostic Procedures (220.5) (cms.gov) |
220.6.1 | PET for Perfusion of the Heart | NCD - PET for Perfusion of the Heart (220.6.1) (cms.gov) |
220.6.13 | FDG PET for Dementia and Neurodegenerative Diseases | NCD - FDG PET for Dementia and Neurodegenerative Diseases (220.6.13) (cms.gov) |
220.6.17 | Positron Emission Tomography (FDG) for Oncologic Conditions | NCD - Positron Emission Tomography (FDG) for Oncologic Conditions (220.6.17) (cms.gov) |
220.6.19 | Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer | NCD - Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer (220.6.19) (cms.gov) |
220.6.20 | Beta Amyloid Positron Tomography in Dementia and Neurodegenerative Disease | NCD - Beta Amyloid Positron Tomography in Dementia and Neurodegenerative Disease (220.6.20) (cms.gov) |
220.6.8 | FDG PET for Myocardial Viability | NCD - FDG PET for Myocardial Viability (220.6.8) (cms.gov) |
220.6.9 | FDG PET for Refractory Seizures | NCD - FDG PET for Refractory Seizures (220.6.9) (cms.gov) |
220.9 | Digital Subtraction Angiography | NCD - Digital Subtraction Angiography (220.9) (cms.gov) |
X
You are about to leave Elite Health Plan website
and go to another site managed by a third party. Once you leave our website, the policies and practices of that site may differ from those of Elite Health Plan. When visiting a third-party website, you will be subject to the privacy and security policies of that specific website.
bottom of page